Market Tracker

04/23 6:05pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

During the Trading Day
1.84 -0.02 / -1.08%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.84 0.00 / 0.00%
 
Volume: 6.5K

Today’s Trading

Previous close1.86
Today’s open1.92
Day’s range1.83 - 1.94
Volume1,269,387
Average volume (3 months)4,215,396
Market cap$333.5M
Dividend yield--
Data as of 3:59pm ET, 04/23/2014

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)+12.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+42.34%
P/E ratioNM
Price/Sales7.72
Price/Book11.44

Competitors

 Today’s
change
Today’s
% change
DRTXDurata Therapeutics ...-0.16-1.19%
RGLSRegulus Therapeutics...-0.28-3.80%
ATNMActinium Pharmaceuti...+0.56+4.45%
DRNADicerna Pharmaceutic...-0.89-5.01%
Data as of 4:00pm ET, 04/23/2014

Financials

Next reporting dateJuly 15, 2014
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$21.7M
Annual profit (last year)-$29.8M
Net profit margin-137.34%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts